Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues FORA Q1 2026 Earnings Steep EPS Miss Overshadows Quarter as Revenue Remains Undisclosed Cango Inc Q4 2025 Earnings Deep EPS Miss Triggers Stock Decline SCI Q1 2026 Earnings EPS Misses Estimates by 44 Shares Edge Higher WAB Q1 2026 Earnings EPS Surpasses Estimates by Nearly 7 MPT Q1 2026 Earnings EPS Surges Past Estimates Yet Shares Edge Lower